Brief: Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results
20/05/2026 11:05
May 20 (Reuters) - Pfizer Inc PFE.N: PFIZER ADVANCES PIVOTAL PEDIATRIC PNEUMOCOCCAL VACCINE PROGRAM FOLLOWING STRONG POSITIVE PHASE 2 RESULTS Source text: ID:nBw62r8Y5a Further company coverage: PFE.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials